NCT02555397 2024-10-10Phase 1 Trial of Interleukin 12 Gene Therapy for Locally Recurrent Prostate CancerHenry Ford Health SystemPhase 1 Completed15 enrolled 11 charts
NCT03384316 2020-09-09Multi-Targeted Recombinant Ad5 (CEA/MUC1/Brachyury) Based Immunotherapy Vaccine Regimen in People With Advanced CancerNational Institutes of Health Clinical Center (CC)Phase 1 Completed11 enrolled 18 charts